Please assess the completion status of the following clinical trial:

Trial Title: Intravenous High Dose Iron in Blood Donors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age ≥18 years and ≤ 65 years~* ferritin ≤ 30 ng/ml~* fulfilment of the strict criteria for blood donation~Exclusion Criteria:~* hemochromatosis~* active infection~* pregnancy or lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Oral Iron (Type: ACTIVE_COMPARATOR): oral iron in a corresponding dose of 10g (assuming an absorption of 10%, 100 capsules a 100mg iron each) taken over 8-12 weeks
- Intravenous high dose iron (Type: EXPERIMENTAL): high dose intravenous iron (ferric carboxymaltose, 1000mg)

Based on this trial design, predict the completion outcome and termination type (if applicable).